IDO2 and autoimmune disease: In the same experimental setting, the specific silencing of IDO2 in B cells significantly reduced total arthritis severity, confirming the role of IDO2 in disease initiation and progression and pinpointing IDO2 as an innovative target for the treatment of this autoimmune disease (21).